Gene · 54890
Papers4,144
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 4,144
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ferroptosis-associated circular RNAs: Opportunities and challenges in the diagnosis and treatment of cancer. | Front Cell Dev Biol | 2023 | 37152286 | PubTator, text mining | PubMed |
| m6A modification on the fate of colorectal cancer: functions and mechanisms of cell proliferation and tumorigenesis. | Front Oncol | 2023 | 37152066 | PubTator, text mining | PubMed |
| Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment. | Int J Biol Sci | 2023 | 37151887 | PubTator, text mining | PubMed |
| m6A methylation regulates hypoxia-induced pancreatic cancer glycolytic metabolism through ALKBH5-HDAC4-HIF1α positive feedback loop. | Oncogene | 2023 | 37149664 | PubTator, text mining | PubMed |
| N6-methyladenine-mediated aberrant activation of the lncRNA SOX2OT-GLI1 loop promotes non-small-cell lung cancer stemness. | Cell Death Discov | 2023 | 37149646 | PubTator, text mining | PubMed |
| Mining glycosylation-related prognostic lncRNAs and constructing a prognostic model for overall survival prediction in glioma: A study based on bioinformatics analysis. | Medicine (Baltimore) | 2023 | 37145002 | PubTator, text mining | PubMed |
| m6A-mediated upregulation of lncRNA-AC026356.1 promotes cancer stem cell maintenance in lung adenocarcinoma via activating Wnt signaling pathway. | Aging (Albany NY) | 2023 | 37142269 | PubTator, text mining | PubMed |
| Integration of epigenetic regulatory mechanisms in heart failure. | Basic Res Cardiol | 2023 | 37140699 | PubTator, text mining | PubMed |
| RNA methylation pattern and immune microenvironment characteristics mediated by m6A regulator in ischemic stroke. | Front Genet | 2023 | 37139237 | PubTator, text mining | PubMed |
| Non-coding RNAs and colitis-associated cancer: Mechanisms and clinical applications. | Clin Transl Med | 2023 | 37138536 | PubTator, text mining | PubMed |
| Integrative multi-omics analysis depicts the methylome and hydroxymethylome in recurrent bladder cancers and identifies biomarkers for predicting PD-L1 expression. | Biomark Res | 2023 | 37138354 | PubTator, text mining | PubMed |
| Research Progress of m6A RNA Methylation in Skin Diseases. | Biomed Res Int | 2023 | 37124930 | PubTator, text mining | PubMed |
| Multiple epigenetic modification profiles reveal the tumor immune microenvironment and clinical outcomes of uveal melanoma. | Front Genet | 2023 | 37124608 | PubTator, text mining | PubMed |
| Potential genetic therapies based on m6A methylation for skin regeneration: Wound healing and scars/keloids. | Front Bioeng Biotechnol | 2023 | 37122849 | PubTator, text mining | PubMed |
| Exosomal circRNAs as promising liquid biopsy biomarkers for glioma. | Front Immunol | 2023 | 37122733 | PubTator, text mining | PubMed |
| Corrigendum to "Discovery of a potent, selective and cell active inhibitor of m6A demethylase ALKBH5" [Eur. J. Med. Chem. 238 (2022) 114446]. | Eur J Med Chem | 2023 | 37119665 | PubTator, text mining | PubMed |
| ALKBH8 as a potential N6 -methyladenosine (m6 A) eraser in insects. | Insect Mol Biol | 2023 | 37119026 | PubTator, text mining | PubMed |
| Genetic Modulation of BET1L Confers Colorectal Cancer Susceptibility by Reducing miRNA Binding and m6A Modification. | Cancer Res | 2023 | 37115853 | PubTator, text mining | PubMed |
| Epigenetic Targets and Their Inhibitors in Thyroid Cancer Treatment. | Pharmaceuticals (Basel) | 2023 | 37111316 | PubTator, text mining | PubMed |
| Alteration of m6A-Tagged RNA Profiles in Bone Originated from Periprosthetic Joint Infection. | J Clin Med | 2023 | 37109200 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54890/papers?page=56